Results 321 to 330 of about 375,661 (389)
Some of the next articles are maybe not open access.
To GERD or not to GERD, this is the question
The Journal of Pediatrics, 2009No abstract ...
TORNESE, GIANLUCA +3 more
openaire +2 more sources
Management of refractory typical GERD symptoms
Nature Reviews Gastroenterology and Hepatology, 2016Daphne Ang +2 more
exaly +2 more sources
Journal of Clinical Gastroenterology, 2007
Gastroesophageal reflux disease (GERD) is a highly prevalent disorder in all Western countries and, in recent years, the prevalence has substantially increased in developing countries. In parallel, there is a remarkable increase of GERD-related fatal and nonfatal complications although these complications are rare on a global scale.
Richard H. Hunt +2 more
openaire +2 more sources
Gastroesophageal reflux disease (GERD) is a highly prevalent disorder in all Western countries and, in recent years, the prevalence has substantially increased in developing countries. In parallel, there is a remarkable increase of GERD-related fatal and nonfatal complications although these complications are rare on a global scale.
Richard H. Hunt +2 more
openaire +2 more sources
Gastroenterology Clinics of North America, 2008
The manifestations of gastroesophageal reflux disease (GERD) have been classified into either esophageal or extraesophageal syndromes. Cough, reflux laryngitis, and asthma have been classified as extraesophageal syndromes, whereas reflux chest pain has been classified as a symptomatic syndrome of GERD.
Jeanetta Walters, Frye, Michael F, Vaezi
openaire +2 more sources
The manifestations of gastroesophageal reflux disease (GERD) have been classified into either esophageal or extraesophageal syndromes. Cough, reflux laryngitis, and asthma have been classified as extraesophageal syndromes, whereas reflux chest pain has been classified as a symptomatic syndrome of GERD.
Jeanetta Walters, Frye, Michael F, Vaezi
openaire +2 more sources
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD)
Expert Opinion on Pharmacotherapy, 2020Introduction Gastroesophageal reflux disease (GERD) is a very common worldwide condition, affecting about 15–20% of the whole population, and representing a major burden for health-care systems.
N. Chapelle +3 more
semanticscholar +1 more source
Nocturnal Gastroesophageal Reflux Disease (GERD) and Sleep
Journal of Clinical Gastroenterology, 2020Gastroesophageal reflux disease (GERD) is a prevalent, chronic medical condition that affects 13% of the adult population globally at least once a week.
Fahmi Shibli +3 more
semanticscholar +1 more source
Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies
Nature Reviews Gastroenterology and Hepatology, 2015 Leila Kia, Ikuo Hirano
exaly +2 more sources
Surgical Innovation, 2015 Background. Incomplete control of troublesome regurgitation and extraesophageal manifestations of chronic gastroesophageal reflux disease (GERD) is a known limitation of proton pump inhibitor (PPI) therapy.
Karim S Trad
exaly +2 more sources
Endoscopic treatments for GERD
Annals of the New York Academy of Sciences, 2020AbstractGastroesophageal reflux disease (GERD) is a condition with increasing prevalence and morbidity in the United States and worldwide. Despite advances in medical and surgical therapy over the last 30 years, gaps remain in the therapeutic profile of options.
Bradley S, Kushner +5 more
openaire +2 more sources
Gastroesophageal reflux disease (GERD) in children
Paediatrics and International Child Health, 2018Background: Gastro-oesophageal reflux (GER) and gastro-oesophageal reflux disease (GERD) are common in infants and children. Aims: To review the recent literature on GERD in children and to outline the approach to diagnosis and management.
U. Poddar
semanticscholar +1 more source